Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abcam E-4031 Dihydrochloride, HERG K+ Channel Blocker, 99% Purity, Solid, 5 mg

Catalog No. 502584672
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-258-4672 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-258-4672 Supplier Abcam Supplier No. AB1201585MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Type III antiarrhythmic drug that blocks ion channels encoded by the ether-a-go-go related gene (ERG1 or KCNH1).

  • Molecular Weight: 474.4 Da
  • Purity: >99%
  • Physical State: Solid
  • Activity: Type III antiarrhythmic drug that blocks ion channels encoded by the ether-a-go-go related gene (ERG1 or KCNH1). Blocks channels in the open configuration with little effect on the channels in the closed configuration. The IC50 for block of human ERG channels in expression systems is approx. 350 nM.
  • Storage: Store at +4°C.
  • Constituents: 100% N-(4-{1-[2-(6-methylpyridin-2-yl)ethyl]piperidine-4-carbonyl}phenyl)methanesulfonamide dihydrochloride

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule HERG K+ Channel
Substrate Properties Chemical Substrate
Shipping Condition Ambient
Format Vial
Product Type Antioxidant
Form Solid
Quantity 5 mg
For Use With (Application) Ion channel blocking
Storage Requirements Store at 4°C.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.